American International Group, Inc. Vir Biotechnology, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$8.6 - $11.9 $3,474 - $4,807	-404 Reduced 0.88%	45,266 $458,000
Q4 2023 Feb 13, 2024	SELL	$7.76 - $10.29 $2,956 - $3,920	-381 Reduced 0.83%	45,670 $459,000
Q3 2023 Nov 13, 2023	BUY	$9.14 - $24.62 $13,673 - $36,831	1,496 Added 3.36%	46,051 $431,000
Q2 2023 Aug 04, 2023	BUY	$23.2 - $27.29 $110,316 - $129,763	4,755 Added 11.95%	44,555 $1.09 Million
Q1 2023 May 12, 2023	BUY	$22.26 - $30.85 $3,361 - $4,658	151 Added 0.38%	39,800 $926,000
Q4 2022 Feb 10, 2023	SELL	$19.96 - $28.22 $5,948 - $8,409	-298 Reduced 0.75%	39,649 $1 Million
Q3 2022 Nov 14, 2022	BUY	$18.26 - $31.1 $9,842 - $16,762	539 Added 1.37%	39,947 $770,000
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $182,442 - $255,305	9,562 Added 32.04%	39,408 $1 Million
Q1 2022 May 13, 2022	SELL	$21.19 - $40.01 $44,499 - $84,021	-2,100 Reduced 6.57%	29,846 $768,000
Q4 2021 Feb 11, 2022	SELL	$30.97 - $54.03 $29,638 - $51,706	-957 Reduced 2.91%	31,946 $1.34 Million
Q3 2021 Nov 12, 2021	SELL	$34.9 - $54.54 $27,256 - $42,595	-781 Reduced 2.32%	32,903 $1.43 Million
Q2 2021 Aug 13, 2021	BUY	$38.75 - $51.0 $95,208 - $125,307	2,457 Added 7.87%	33,684 $1.59 Million
Q1 2021 May 07, 2021	BUY	$26.34 - $83.07 $2,159 - $6,811	82 Added 0.26%	31,227 $1.6 Million
Q4 2020 Feb 12, 2021	SELL	$25.51 - $43.38 $22,805 - $38,781	-894 Reduced 2.79%	31,145 $834,000
Q3 2020 Nov 04, 2020	BUY	$28.28 - $53.6 $105,229 - $199,445	3,721 Added 13.14%	32,039 $1.1 Million
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $670,838 - $1.15 Million	24,053 Added 563.96%	28,318 $1.16 Million
Q1 2020 May 04, 2020	SELL	$12.04 - $60.2 $2,973 - $14,869	-247 Reduced 5.47%	4,265 $146,000
Q4 2019 Feb 05, 2020	BUY	$11.83 - $15.85 $53,376 - $71,515	4,512 New	4,512 $57,000

Others Institutions Holding VIR

# of Institutions

218

Shares Held

87M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$123 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$122 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$97.2 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$41.6 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$26.4 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account